PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
GMRE vs. SWBI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between GMRE and SWBI is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

GMRE vs. SWBI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Global Medical REIT Inc. (GMRE) and Smith & Wesson Brands, Inc. (SWBI). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-12.89%
-30.23%
GMRE
SWBI

Key characteristics

Sharpe Ratio

GMRE:

-0.52

SWBI:

-0.35

Sortino Ratio

GMRE:

-0.58

SWBI:

-0.23

Omega Ratio

GMRE:

0.93

SWBI:

0.96

Calmar Ratio

GMRE:

-0.28

SWBI:

-0.24

Martin Ratio

GMRE:

-1.10

SWBI:

-0.81

Ulcer Index

GMRE:

12.13%

SWBI:

20.70%

Daily Std Dev

GMRE:

25.44%

SWBI:

48.05%

Max Drawdown

GMRE:

-58.92%

SWBI:

-96.59%

Current Drawdown

GMRE:

-43.37%

SWBI:

-66.78%

Fundamentals

Market Cap

GMRE:

$550.34M

SWBI:

$460.27M

EPS

GMRE:

-$0.02

SWBI:

$0.78

Total Revenue (TTM)

GMRE:

$107.92M

SWBI:

$514.64M

Gross Profit (TTM)

GMRE:

$75.91M

SWBI:

$158.31M

EBITDA (TTM)

GMRE:

$73.54M

SWBI:

$73.45M

Returns By Period

In the year-to-date period, GMRE achieves a 4.15% return, which is significantly higher than SWBI's 3.51% return.


GMRE

YTD

4.15%

1M

2.29%

6M

-12.89%

1Y

-15.28%

5Y*

-4.43%

10Y*

N/A

SWBI

YTD

3.51%

1M

4.18%

6M

-30.24%

1Y

-18.30%

5Y*

10.99%

10Y*

2.28%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

GMRE vs. SWBI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GMRE
The Risk-Adjusted Performance Rank of GMRE is 2121
Overall Rank
The Sharpe Ratio Rank of GMRE is 1919
Sharpe Ratio Rank
The Sortino Ratio Rank of GMRE is 1818
Sortino Ratio Rank
The Omega Ratio Rank of GMRE is 1919
Omega Ratio Rank
The Calmar Ratio Rank of GMRE is 2929
Calmar Ratio Rank
The Martin Ratio Rank of GMRE is 1919
Martin Ratio Rank

SWBI
The Risk-Adjusted Performance Rank of SWBI is 2727
Overall Rank
The Sharpe Ratio Rank of SWBI is 2727
Sharpe Ratio Rank
The Sortino Ratio Rank of SWBI is 2525
Sortino Ratio Rank
The Omega Ratio Rank of SWBI is 2424
Omega Ratio Rank
The Calmar Ratio Rank of SWBI is 3131
Calmar Ratio Rank
The Martin Ratio Rank of SWBI is 2828
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

GMRE vs. SWBI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Global Medical REIT Inc. (GMRE) and Smith & Wesson Brands, Inc. (SWBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for GMRE, currently valued at -0.52, compared to the broader market-2.000.002.004.00-0.52-0.35
The chart of Sortino ratio for GMRE, currently valued at -0.58, compared to the broader market-4.00-2.000.002.004.006.00-0.58-0.23
The chart of Omega ratio for GMRE, currently valued at 0.93, compared to the broader market0.501.001.502.000.930.96
The chart of Calmar ratio for GMRE, currently valued at -0.28, compared to the broader market0.002.004.006.00-0.28-0.24
The chart of Martin ratio for GMRE, currently valued at -1.10, compared to the broader market0.0010.0020.0030.00-1.10-0.81
GMRE
SWBI

The current GMRE Sharpe Ratio is -0.52, which is lower than the SWBI Sharpe Ratio of -0.35. The chart below compares the historical Sharpe Ratios of GMRE and SWBI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
-0.52
-0.35
GMRE
SWBI

Dividends

GMRE vs. SWBI - Dividend Comparison

GMRE's dividend yield for the trailing twelve months is around 10.45%, more than SWBI's 4.88% yield.


TTM202420232022202120202019201820172016
GMRE
Global Medical REIT Inc.
10.45%10.88%7.57%8.86%5.77%6.13%6.05%9.00%9.76%4.48%
SWBI
Smith & Wesson Brands, Inc.
4.88%5.05%3.39%4.38%1.63%0.56%0.00%0.00%0.00%0.00%

Drawdowns

GMRE vs. SWBI - Drawdown Comparison

The maximum GMRE drawdown since its inception was -58.92%, smaller than the maximum SWBI drawdown of -96.59%. Use the drawdown chart below to compare losses from any high point for GMRE and SWBI. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%AugustSeptemberOctoberNovemberDecember2025
-43.37%
-66.78%
GMRE
SWBI

Volatility

GMRE vs. SWBI - Volatility Comparison

Global Medical REIT Inc. (GMRE) has a higher volatility of 8.85% compared to Smith & Wesson Brands, Inc. (SWBI) at 8.11%. This indicates that GMRE's price experiences larger fluctuations and is considered to be riskier than SWBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%AugustSeptemberOctoberNovemberDecember2025
8.85%
8.11%
GMRE
SWBI

Financials

GMRE vs. SWBI - Financials Comparison

This section allows you to compare key financial metrics between Global Medical REIT Inc. and Smith & Wesson Brands, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab